Determination of Lung Maturity and Prediction of RDS at Birth
NCT ID: NCT02076126
Last Updated: 2015-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
145 participants
OBSERVATIONAL
2014-03-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We have therefore developed a quick test, which we believe will be ideal for this type of diagnostics, and will now test the method in a preclinical trial.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aspirates will be frozen at -20 centigrade and lecithin-sphingomyelin ratio (L/S) will be analysed retrospectively using Fourier Transform Infrared Spectroscopy.
The infants will be monitored for the first five days with regard to possible development of RDS.
Clinical and biochemical data will be compared retrospectively.
There a no intervention procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastric aspirate
L/S ratio on the gastric aspirates are retrospectively compared with the possible development of RDS
No interventions assigned to this group
Hypopharyngeal secretion
L/S ratio on the hypopharyngeal secretions are retrospectively compared with the possible development of RDS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \< ½ hour
Exclusion Criteria
* lack of aspirate
1 Minute
30 Minutes
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Holbaek Sygehus
OTHER
Aalborg University Hospital
OTHER
Odense University Hospital
OTHER
Aarhus University Hospital Skejby
OTHER
Kolding Sygehus
OTHER
Copenhagen University Hospital at Herlev
OTHER
Rigshospitalet, Denmark
OTHER
Hvidovre University Hospital
OTHER
Naestved Hospital
OTHER
University Hospital, Linkoeping
OTHER
Skane University Hospital
OTHER
Henrik Axel Verder
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henrik Axel Verder
Professor DMSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Verder, Professor MD
Role: PRINCIPAL_INVESTIGATOR
Holbaek Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Holbaek Sygehus
Holbæk, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Holb.SJ-384
Identifier Type: -
Identifier Source: org_study_id